Elan continues assets disposal
Elan today continued its disposals spree with the sale of its European sales and marketing business.
Elan stands to make around $120m (€96m) from the sale to Medeus UK, a new pharmaceutical company backed by private equity firm Apax Partners.
CONNECT WITH US TODAY
Be the first to know the latest news and updates